Mollee P - Search Results

1

A Comparison of High-Dose Cytarabine During Induction Versus Consolidation Therapy in Newly Diagnosed AML.

Schwarer AP, Butler J, Jackson K, Beligaswatte A, Martin L, Kennedy G, Daniela Z, Lewis I, Hiwase D, Wight J, He S, Grigg A, Morris K, Mollee P, Marlton P. Schwarer AP, et al. Among authors: mollee p. Hemasphere. 2018 Nov 28;2(6):e158. doi: 10.1097/HS9.0000000000000158. eCollection 2018 Dec. Hemasphere. 2018. PMID: 31723796 Free PMC article.

2

Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma.

Gandhi MK, Lambley E, Burrows J, Dua U, Elliott S, Shaw PJ, Prince HM, Wolf M, Clarke K, Underhill C, Mills T, Mollee P, Gill D, Marlton P, Seymour JF, Khanna R. Gandhi MK, et al. Among authors: mollee p. Clin Cancer Res. 2006 Jan 15;12(2):460-4. doi: 10.1158/1078-0432.CCR-05-2008. Clin Cancer Res. 2006. PMID: 16428487

3

The Hyper-CVAD chemotherapy regimen has an adverse long-term impact on the ability to mobilize peripheral blood stem cells, which can be readily circumvented by using the early cycles for mobilization.

Keane C, Gibbs S, Seymour JF, Mills AK, Grimmett K, Van Kuilenberg R, Saal R, Gill D, Prince HM, Marlton P, Mollee P. Keane C, et al. Among authors: mollee p. Hematol Oncol. 2006 Sep;24(3):159-63. doi: 10.1002/hon.784. Hematol Oncol. 2006. PMID: 16775841

4

Outcomes and prognostic factors for patients with acute myeloid leukemia admitted to the intensive care unit.

Jackson K, Mollee P, Morris K, Butler J, Jackson D, Kruger P, Klein K, Kennedy G. Jackson K, et al. Among authors: mollee p. Leuk Lymphoma. 2014 Jan;55(1):97-104. doi: 10.3109/10428194.2013.796045. Epub 2013 May 29. Leuk Lymphoma. 2014. PMID: 23597137

5

Intensive chemotherapy and reduced-intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in elderly patients.

Jackson K, Kennedy G, Mollee P, Marlton P, Morris K. Jackson K, et al. Among authors: mollee p. Asia Pac J Clin Oncol. 2014 Sep;10(3):246-54. doi: 10.1111/ajco.12188. Epub 2014 Mar 27. Asia Pac J Clin Oncol. 2014. PMID: 24673966

6

Cessation of immunosuppression during chemotherapy for post-transplant lymphoproliferative disorders in renal transplant patients.

Taylor E, Jones M, Hourigan MJ, Johnson DW, Gill DS, Isbel N, Hawley CM, Marlton P, Gandhi MK, Campbell SB, Mollee P. Taylor E, et al. Among authors: mollee p. Nephrol Dial Transplant. 2015 Oct;30(10):1774-9. doi: 10.1093/ndt/gfv260. Epub 2015 Jul 18. Nephrol Dial Transplant. 2015. PMID: 26188340

7

Partial response after induction chemotherapy has clinical relevance in acute myeloid leukaemia.

Fleming S, Ong DM, Jackson K, Avery S, Mollee P, Marlton P, Kennedy G, Wei AH. Fleming S, et al. Among authors: mollee p. Br J Haematol. 2017 Apr;177(2):328-330. doi: 10.1111/bjh.14063. Epub 2016 Mar 31. Br J Haematol. 2017. PMID: 27029236 Free article. No abstract available.

8

Outcomes of stage I/II follicular lymphoma in the PET era: an international study from the Australian Lymphoma Alliance.

Tobin JWD, Rule G, Colvin K, Calvente L, Hodgson D, Bell S, Dunduru C, Gallo J, Tsang ES, Tan X, Wong J, Pearce J, Campbell R, Tneh S, Shorten S, Ng M, Cochrane T, Tam CS, Abro E, Hawkes E, Hodges G, Kansara R, Talaulikar D, Gilbertson M, Johnston AM, Savage KJ, Villa D, Morris K, Ratnasingam S, Janowski W, Kridel R, Cheah CY, MacManus M, Matigian N, Mollee P, Gandhi MK, Hapgood G. Tobin JWD, et al. Among authors: mollee p. Blood Adv. 2019 Oct 8;3(19):2804-2811. doi: 10.1182/bloodadvances.2019000458. Blood Adv. 2019. PMID: 31570492 Free PMC article.

9

Concurrent lipidomics and proteomics on malignant plasma cells from multiple myeloma patients: Probing the lipid metabolome.

Mohamed A, Collins J, Jiang H, Molendijk J, Stoll T, Torta F, Wenk MR, Bird RJ, Marlton P, Mollee P, Markey KA, Hill MM. Mohamed A, et al. Among authors: mollee p. PLoS One. 2020 Jan 8;15(1):e0227455. doi: 10.1371/journal.pone.0227455. eCollection 2020. PLoS One. 2020. PMID: 31914155 Free PMC article.

10

The association of mobilising regimen on immune reconstitution and survival in myeloma patients treated with bortezomib, cyclophosphamide and dexamethasone induction followed by a melphalan autograft.

Rees MJ, Mollee P, Ng JY, Murton A, Gonsalves JF, Panigrahi A, Beer H, Loh J, Nguyen P, Hunt S, Jina H, Wayte R, Sutrave G, Tan J, Abeyakoon C, Chee A, Augustson B, Kalro A, Lee C, Agrawal S, Churilov L, Chua CC, Lim ABM, Zantomio D, Grigg A. Rees MJ, et al. Among authors: mollee p. Bone Marrow Transplant. 2021 Sep;56(9):2152-2159. doi: 10.1038/s41409-021-01300-2. Epub 2021 Apr 28. Bone Marrow Transplant. 2021. PMID: 33911199

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183 results

Search Page

Filters